Effect of autologous bone marrow stem cell transplantation on lower-extremity neuropathy: 3 cases
Gu Yong-quan,Zhang Jian,Qi Li-xing,Liang Bin,FENG Kai,Liao Chuan-jun,Guo Lian-rui,Zhang Shu-wen,Li jian-xin,Wang Zhong-gao
DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.18.027
2005-01-01
Abstract:Aim: To investigate the effect of autologous bone marrow stem cell transplantation(BMSCT) on lower-extremity neuropathy. Methods: A retrospective analysis was made in clinical data of 3 patients suffering from lower-extremity neuropathy who received autologous BMSCT in the Department of Vascular Surgery, Xuanwu Hospital, Capital University of Medical Sciences between October 2003 and July 2004. 1 Patient 1(female): She complained of numbness and mild pain in her left lower limb due to a 10-year history of diabetes mellitus, and she had been diagnosed as left diabetic foot accompanied by distal neuritis. Autologous bone marrow stem cells were injected intramuscularly into the local affected lower limb. 2 Patient 2(male): He was diagnosed as having right diabetic foot with distal neuritis after hospitalization doe to anaesthesia in his right lower limb with 15-year diabetes mellitus. Autologous BMSCT was performed in his right lower limb in the same way as in the patient 1. 3 Patient 3(female): She, who had been with ventricular fibrillation in her rheumatic heart for 10 years and sudden pain in her right lower limb for 2 days, was examined with secondary thrombus after embolectomy in a local hospital. Then, her arterial blood flow of lower extremity recovered to normal after urokinase thrombolysis in our hospital, but she was also accompanied by common peroneal nerve injury and foot drop in her right lower extremity as well as severe toe pain. Having been diagnosed as having ischemic neuralgia, she received autologous BMSCT by two approaches: local intramuscular injection and arterial intraluminal injection. Results: 1 For patient 1: After autologous BMSCT, the pain was relieved nearly at 5 days; the numbness was greatly relieved at 2 weeks, and completely relieved after 3 months. In the electromyogram (EMG) examination, it was shown that the conduction velocity of common peroneal nerve and post-tibial nerve was decelerated in her left lower extremity, which was still faster than that before transplantation. No recurrent symptoms were found after 15-month follow-up. 2 For patient 2: Shown by EMG examination on January 25, 2005, the conduction velocity of common peroneal nerve and post-tibial nerve was 36 meters per second. He received local intramuscular injection of stem cells in right lower extremity under epidural anesthesia on January 28, 2005. After transplantation, the pain was greatly relieved at 5 days; the numbness was remarkably relieved at 2 weeks, and disappeared in his night lower limb and was relieved obviously in his right foot at 1 month. Shown by EMG examination on April 06, 2005, the conduction velocity of common peroneal nerve and post-tibial nerve was 34 meters per second, which was faster than that before operation to some extent. On April 19, 2005, autogolous stem cells were sequentially injected into arterial lumens and into local ischemic muscles both in his right lower extremity through catheters under local and epidural anesthesia. The foot numbness was remarkably relieved at 1 week and disappeared at 10 days after operation. 3 For patient 3: As shown by EMG examination on July 17, 2004, the latent period of the motor end of her right tibial nerve(the medial head of popliteal-sural muscle) was 3.6 ms, and the amplitude of motor conduction potential was 5.1 mV. Sensorimotor conduction potential disappeared in her right tibial nerve(between popliteal fossa and hallucis abductor), common peroneal nerve and sural nerve accompanied by severe toe pain. Autologous BMSCT was performed under epidural anesthesia on July 18, 2004. On the right night of operation, she had relieved toe pain and good sleep. Her right foot has the want-to-move sensation at about 1 week, the toe pain disappeared and the toes were slightly movable at one month after operation. Her toe strength was up to grade 3 at three months after operation, and she could move out of bed, limpingly but walkably at 6 months after operation. The EMG examination on March 16, 2005 showed that the latent period of the motor end of right tibial nerve(the medial head, of popliteal-sural muscle) was shortened to 2.8 ms, and the amplitude of motor conduction potential was promoted to 7.4 mV; The right common peroneal nerve(between inferior fibular capitulum and anterior tibial muscle) revealed a motor conduction potential as low as 0.13 mV; Motor potential disappeared in the right tibial nerve(between medial malleolus and hallucis abductor) and right common peroneal nerve(between superior lateral malleolus and short toe extensor muscle); No sensory conduction potential was detected in the right tibial and sural nerve. She could walk by herself and nearly had a normal life up to now. Conclusion: Autologous BMSCT is undoubtedly a feasible choice for the treatment of lower-extremity neuropathy until a more effective method can be found in the future. This therapy is worthy of further observation and practice.